In just over a week, the global
#cardiology
community will unite at
#ESCCongress
2024. Are you ready to be part of it?
Unable to join us in London? ESC Congress Online brings all the action to you!
.
@escardio
does not endorse the unfortunate personal post by one of its social media ambassadors. Diego Araiza has publicly apologised and will no longer be an ambassador for the society, as his message infringed ESC social media guidelines.
#ADVOR
trial: acetazolamide added to intravenous loop diuretics decreases congestion within 3 days in patients with acute decompensated
#heartfailure
.
#ESCCongress
#Semaglutide
improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with
#HFpEF
and
#obesity
⬇️
#ESCCongress
STEP-HFpEF trial
Share your technology or innovation with the cardiac community.
Two great opportunities to present your digital health solutions during ESC Congress / ESC Digital Summit 2019. Submit by 28 June
#TIME
trial: randomised trial in more than 21,000 patients with high blood pressure has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.
#ESCCongress
JUST RELEASED: 2019
#ESGuidelines
on Diabetes, Pre-Diabetes and Cardiovascular Diseases - what's new? what has changed? what are the main 2019 recommendations?
#ESCCongress
#cardiotwitter
#REVIVED
trial: Percutaneous coronary intervention does not reduce all-cause mortality or
#heartfailure
hospitalisation in patients with severe left ventricular dysfunction and extensive
#coronary
artery disease.
#ESCCongress
In iron-deficient patients with
#HeartFailure
and reduced or mildly reduced left ventricular ejection fraction (
#LVEF
), intravenous ferric carboxymaltose (FCM) is associated with a reduced risk of the composite outcome of total CV hospitalisation and CV death through 52 weeks
Man vs machine: will AI replace human intelligence?
Have your say & play an active role during
#ESCDigital
Summit 2019 - the only digital health event dedicated to cardiology.
Register by 5 August for the greatest savings
#FRAME_AMI
trial: Selection of non-infarct related artery lesions for intervention using fractional flow reserve is superior to routine angiography-based selection in patients with acute
#myocardialinfarction
and multivessel disease.
#ESCCongress
#Afib
ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage
#HeartFailure
#ESCCongress
CASTLE-HTx trial - Catheter ablation versus medical
#eBRAVE_AF
trial:
#AFib
screening using conventional smartphones more than doubles the detection and treatment rate in older people compared to routine screening.
#ESCCongress
A randomised trial involving all hospitals in London, UK, has found no difference in survival at 30 days in patients with resuscitated cardiac arrest in the community who were taken by ambulance to a
#cardiacarrest
centre compared with those delivered to the geographically
Early initiation of the sodium glucose co-transporter 2 (
#SGLT2
) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual care in hospitalised patients with acute decompensated heart failure (ADHF).
We are deeply saddened by the passing of our dear friend and colleague Prof Maurizio Galderisi who succumbed to COVID-19 this morning. Our thoughts go out to his family. The cardiovascular community has lost an inspiring leader. We will miss him dearly.
#EACVI
#COVID19
'To me, it's the greatest event on the planet' 😊 👇
Be part of the onsite magic at
#ESCCongress
2022. Catch up with old friends and meet new colleagues in person.
Find out more & register 😊
#cardiotwitter
#medtwitter
'Bible of CV Medicine'😊as one of our fans refers to the ESC Textbook of Cardiovascular Medicine, 2019 BMA Book Award 1st Prize winner in
#cardiology
ESC Professional Member? You have full access to its online version
#ESCCardioMed
Make the most of it
Austin Flint murmur is assoc w/ severe aortic regurgitation. The result of mitral valve leaflet displacement & turbulent mixing of anterograde mitral & retrograde aortic flow. Thank you
@Doc_Tiger
for this video.
#CVimaging
#cardiotwitter
#cardiacimaging
#EACVI
#APAF
-CRT trial: ablation plus
#CRT
is superior to pharmacological rate control in reducing mortality in severely symptomatic permanent
#AFib
patients with a narrow QRS
#ESCCongress
NEW:
#ESCGuidelines
for Diagnosis and Treatment for Acute and Chronic
#HeartFailure
Algorithm for the treatment of patients with advanced
#HF
👇
Do you know how to select patients with advanced heart failure for mechanical support? 👇
#ESCCongress
The CV scientific meeting of the year is moving online, full speed ahead:
#ESCCongress
2020-Challenging Times, Infinite Possibilities
Sat 29 August-Tue 1 September
Details on free registration will be shared soon.
#cardiotwitter
#Cardiology
#MedTwitter
The traditional Chinese medicine qiliqiangxin reduces hospitalisation for
#HeartFailure
and CV death in patients with
#HF
and a reduced ejection fraction (
#HFrEF
) ⬇️
#ESCCongress
QUEST trial
Upgrade to cardiac resynchronisation therapy with a defibrillator (CRT-D) reduces morbidity & mortality and improves left ventricular reverse remodelling compared to an ICD in select patients with
#HeartFailure
and
#HFrEF
and intermittent or permanent RV pacing ⬇️
#ESCCongress
From today until 31 July, enjoy free access to all ESC 365 content. Explore more than 120,000 presentations, slides, videos, abstracts from past ESC Congresses and across all ESC subspecialty congresses
#cardiotwitter
#medtwitter
#ESCYoung
#cardiology
According to the 2018
#ESCGuidelines
for a Fabulous
#Xmas
Holiday, as long as you spend your winter celebrations w/ good humor, hope & positivity for you, your loved ones & your patients… any dessert is recommended 😃
Our best wishes to you all & Happy New Year!
#PERSPECTIVE
trial: sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with
#heartfailure
and mildly reduced or preserved ejection fraction.
#ESCCongress
We have all lost a great man. Alain Cribier was a revolutionary, devoting his life to innovation, enabling millions of patients to live longer lives.
« This passing of Alain Cribier is very sad news. He was a giant in his field and combined his great expertise with a touching
#ALL_HEART
trial: allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or
#cardiovascular
death in patients with ischaemic heart disease.
#ESCCongress
Immediate multivessel
#PCI
is non-inferior to staged multivessel PCI for reducing death and ischaemic events in patients with
#STEMI
and multivessel coronary artery disease ⬇️
#ESCCongress
MULTISTARS AMI trial - Multivessel immediate versus staged revascularisation in STEMI
#Colchicine
does not significantly reduce perioperative
#Afib
or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery ⬇️
#ESCCongress
COP-AF trial
#HFpEF
is a challenging phenotype of
#HeartFailure
. Until recently, there were no approved or effective therapies to reduce mortality/morbidity.
Clinical trials now show that the outcome of patients with HFpEF could be improved via the use of the news drugs,
#SGLT2i
and
#ARNi
#EchoNet_RCT
: In patients undergoing echocardiographic evaluation of
#cardiac
function, preliminary assessment by artificial intelligence is superior to initial sonographer assessment.
#ESCCongress
What is the pathology of the mitral valve ? – by Miss Solange Fernandes, Barts Health Trust, London
A) Double orifice
B) Rheumatic
C) Hypoplastic
D) Parachute
E) Arcade
#HFA_ESC
#ESCACCA
#EACVI
#cardiotwitter
Extended
#P2Y12
inhibitor monotherapy beyond 12 months after
#PCI
reduces bleeding and ischaemic events in
#ACS
patients at high risk for both types of events.
#ESCCongress
OPT-BIRISK trial - Extended clopidogrel monotherapy versus DAPT in high-risk patients.
JUST RELEASED: 2019
#ESCGuidelines
for the management of Supraventricular Tachycardia - what's new? what has changed? what are the main 2019 recommendations?
#ESCcongress
#cardiotwitter
#EMPEROR
-Pooled trial: a pooled analysis of two randomised trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction
#ESCCongress
#DANFLU_1
trial: Innovative randomised trial shows high-dose influenza vaccination in older adults is associated with a reduced risk of death and lower incidence of hospitalisation for influenza or pneumonia compared with standard-dose vaccination.
#ESCCongress
All you need to know about
#CVD
and
#diabetes
👇
This month’s Focus has a special emphasis on the new
#ESCGuidelines
and how to overcome challenges in their implementation. These include
#ESCCongresspresentations
, webinars, journal articles, a textbook chapter and an ESC
Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided
#PCI
⬇️
#ESCCongress
OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis
A hearty round of applause to this year's winners at
#ESCCongress
. The path to finalising, submitting, and showcasing research demands dedication. Review the winning presentations
Congratulations to everyone again😊 Well done!